Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
European Journal of Cancer (Oxford, England : 1990)
|
August 3, 2013
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study
J A Kohler, H Rubie, V Castel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 1997
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology
C Coze, O Hartmann, J Michon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle
G Michel, G Socié, F Gebhard, et al.
British Journal of Cancer
|
September 4, 2008
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
B De Bernardi, V Mosseri, H Rubie, et al.
British Journal of Cancer
|
July 2, 1998
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)
H Rubie, J Michon, D Plantaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique
H Rubie, O Hartmann, J Michon, et al.
British Journal of Cancer
|
September 20, 2000
Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncology
V Minard, O Hartmann, M C Peyroulet, et al.
British Journal of Haematology
|
August 29, 1998
Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study
P Bordigoni, H Esperou, G Souillet, et al.
Cancer Research
|
February 11, 1998
A lack of neuroblastoma in Down syndrome: a study from 11 European countries
D Satgé, A J Sasco, N L Carlsen, et al.
British Journal of Cancer
|
December 8, 2011
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
G Schleiermacher, J Michon, A Ribeiro, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
European Journal of Cancer (Oxford, England : 1990)
|
August 3, 2013
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study
J A Kohler, H Rubie, V Castel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 1997
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology
C Coze, O Hartmann, J Michon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle
G Michel, G Socié, F Gebhard, et al.
British Journal of Cancer
|
September 4, 2008
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
B De Bernardi, V Mosseri, H Rubie, et al.
British Journal of Cancer
|
July 2, 1998
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)
H Rubie, J Michon, D Plantaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique
H Rubie, O Hartmann, J Michon, et al.
British Journal of Cancer
|
September 20, 2000
Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncology
V Minard, O Hartmann, M C Peyroulet, et al.
British Journal of Haematology
|
August 29, 1998
Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study
P Bordigoni, H Esperou, G Souillet, et al.
Cancer Research
|
February 11, 1998
A lack of neuroblastoma in Down syndrome: a study from 11 European countries
D Satgé, A J Sasco, N L Carlsen, et al.
British Journal of Cancer
|
December 8, 2011
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
G Schleiermacher, J Michon, A Ribeiro, et al.
Page
of 10